Ceria‐based therapeutic antioxidants for biomedical applications
The growing interest in nanomedicine over the last 20 years has carved out a research field
called “nanocatalytic therapy,” where catalytic reactions mediated by nanomaterials are …
called “nanocatalytic therapy,” where catalytic reactions mediated by nanomaterials are …
[HTML][HTML] Mitochondrial reactive oxygen species and their contribution in chronic kidney disease progression through oxidative stress
H Tirichen, H Yaigoub, W Xu, C Wu, R Li… - Frontiers in physiology, 2021 - frontiersin.org
Mitochondria are known to generate approximately 90% of cellular reactive oxygen species
(ROS). The imbalance between mitochondrial reactive oxygen species (mtROS) production …
(ROS). The imbalance between mitochondrial reactive oxygen species (mtROS) production …
[HTML][HTML] GSDME-mediated pyroptosis promotes the progression and associated inflammation of atherosclerosis
Y Wei, B Lan, T Zheng, L Yang, X Zhang… - Nature …, 2023 - nature.com
Pyroptosis, a type of Gasdermin-mediated cell death, contributes to an exacerbation of
inflammation. To test the hypothesis that GSDME-mediated pyroptosis aggravates the …
inflammation. To test the hypothesis that GSDME-mediated pyroptosis aggravates the …
Extracellular vesicles: A bright star of nanomedicine
P Wu, B Zhang, DKW Ocansey, W Xu, H Qian - Biomaterials, 2021 - Elsevier
Extracellular vesicles (EVs) have unique structural, compositional, and morphological
characteristics as well as predominant physiochemical stability and biocompatibility …
characteristics as well as predominant physiochemical stability and biocompatibility …
NLRP3 inflammasome and the IL-1 pathway in atherosclerosis
A Grebe, F Hoss, E Latz - Circulation research, 2018 - Am Heart Assoc
Inflammation is an important driver of atherosclerosis, the underlying pathology of
cardiovascular diseases. Therefore, therapeutic targeting of inflammatory pathways is …
cardiovascular diseases. Therefore, therapeutic targeting of inflammatory pathways is …
The immunology of atherosclerosis
A Gisterå, GK Hansson - Nature reviews nephrology, 2017 - nature.com
Cardiovascular disease is the leading cause of death worldwide, both in the general
population and among patients with chronic kidney disease (CKD). In most cases, the …
population and among patients with chronic kidney disease (CKD). In most cases, the …
HDAC6 mediates an aggresome-like mechanism for NLRP3 and pyrin inflammasome activation
VG Magupalli, R Negro, Y Tian, AV Hauenstein… - Science, 2020 - science.org
INTRODUCTION Canonical inflammasomes are multicomponent protein complexes that
play key roles in immune surveillance of infections and danger by activating caspase-1 …
play key roles in immune surveillance of infections and danger by activating caspase-1 …
Akkermansia Muciniphila Protects Against Atherosclerosis by Preventing Metabolic Endotoxemia-Induced Inflammation in Apoe−/− Mice
Background—Altered composition of the gut microbiota is involved in both the onset and
progression of obesity and diabetes mellitus. However, the link between gut microbiota and …
progression of obesity and diabetes mellitus. However, the link between gut microbiota and …
Clinical relevance of biomarkers of oxidative stress
J Frijhoff, PG Winyard, N Zarkovic… - Antioxidants & redox …, 2015 - liebertpub.com
Significance: Oxidative stress is considered to be an important component of various
diseases. A vast number of methods have been developed and used in virtually all diseases …
diseases. A vast number of methods have been developed and used in virtually all diseases …
CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis
Atherosclerosis is the disease process that underlies heart attack and stroke. Advanced
lesions at risk of rupture are characterized by the pathological accumulation of diseased …
lesions at risk of rupture are characterized by the pathological accumulation of diseased …